MARKET

DCOIF

DCOIF

DICOT PHARMA AB
Grey
--
NaN%
Closed
OPEN
--
PREV CLOSE
--
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
--
52 WEEK LOW
--
MARKET CAP
--
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
1D
No Data
About DCOIF
Dicot Pharma AB, formerly known as Dicot AB is Sweden- based drug pharmaceutical company primarily engaged in the drug development industry. The Company scope of activity revolves around developing innovations that enhance sexual health. The company develops and manufactures medicines for the treatment of erectile dysfunction and premature ejaculation. The company's lead candidate is LIB-01 which is in the clinical testing. The Company conducted comprehensive preclinical studies, verifying LIB-01’s effect across multiple studies. The active substance in LIB-01 is a semi-synthetically produced molecule based on a folk medicine use. Dicot Pharma AB goal is to develop a completely new generation of potency drugs.

Webull offers Dicot Pharma AB stock information, including Grey: DCOIF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DCOIF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DCOIF stock methods without spending real money on the virtual paper trading platform.